FDA Adverse Event Injury Summary report: N

TAXUS? ELEMENT?

MDR report key: 2920593 · Received January 17, 2013

Report

Report Number
2134265-2013-00058
Event Type
Injury
Date Received
January 17, 2013
Date of Event
April 25, 2012
Report Date
December 19, 2012
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
P100023
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
ES
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

PATIENT IDENTIFIER: (B)(6). DEVICE IS COMBINATION PRODUCT. DEVICE EVALUATED BY MFR: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF BATCH HISTORY, HISTORICAL TRENDING AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

(B)(4). SAME PATIENT AS MDR #2134265-2013-00424. IT WAS FURTHER REPORTED THAT THE PATIENT WAS TREATED FOR ANEMIA 2 DAYS AFTER THE PROCEDURE. FIVE DAYS AFTER INITIAL PROCEDURE, A SECOND LESION WAS TREATED. IT WAS LOCATED IN THE PROXIMAL LEFT CIRCUMFLEX ARTERY AND WAS DESCRIBED AS 16MM LONG, WITH A VESSEL DIAMETER OF 2.25MM AND 95% STENOSIS. AFTER PREDILATION A 2.25X16MM TAXUS ELEMENT STENT WAS IMPLANTED WITH 0% RESIDUAL STENOSIS. .

Description of Event or Problem · 1

SAME PATIENT AS MDR#2134265-2013-00424. (B)(4) TRIAL. IT WAS REPORTED POST A PERCUTANEOUS CORONARY INTERVENTION (PCI) WITH STENT IMPLANTATION MYOCARDIAL INFARCTION (MI) OCCURRED. THE PATIENT PRESENTED DUE TO SILENT ISCHEMIA AND WAS REFERRED FOR CARDIAC CATHETERIZATION. THE TARGET LESION WAS LOCATED IN THE LEFT ANTERIOR DESCENDING ARTERY (LAD). IT WAS DESCRIBED AS 22MM LONG, WITH A VESSEL DIAMETER OF 2.5 MM AND 85% STENOSIS. THE LESION WAS TREATED WITH IMPLANTATION OF A 2.50 MM X 24 MM TAXUS ELEMENT STENT, WITH 0% RESIDUAL STENOSIS. THE PATIENT WAS DISCHARGED SEVEN DAYS LATER ON ASPIRIN AND CLOPIDOGREL. ON (B)(6) 2012 THE PATIENT PRESENTED WITH PROGRESSIVE INCREASED DYSPNEA, CRUSHING CHEST PAIN RADIATING TOWARDS THE BACK AND INCREASING RIGHT FOOT PAIN. HE WAS HOSPITALIZED ON THE SAME DAY. ELEVATED TROPONIN VALUE WAS OBSERVED AND MI WAS REPORTED. ECG WAS PERFORMED AND THE SUBJECT EXPERIENCED ISCHEMIC SYMPTOMS. ADDITIONALLY RIGHT LOWER LIMB SUPER INFECTION WAS SUSPECTED AND THE PATIENT WAS REFERRED TO THE VASCULAR SURGERY DEPARTMENT. IT WAS DIAGNOSED AS GRADE IV CHRONIC ARTERIAL INSUFFICIENCY WITH SUPER INFECTION. HE WAS SHIFTED TO THE INTERNAL MEDICINE DEPARTEMENT. THE PATIENT WAS ALSO DIAGNOSED WITH ANOTHER EPISODE OF MULTI-FACTORIAL ANEMIA. MEDICATION WAS GIVEN TO TREAT THE MI AND SEPSIS. THE EVENT WAS CONSIDERED NOT RESOLVED. FIVE DAYS LATER THE PATIENT EXPIRED. THE CAUSE OF THE DEATH WAS "SEPSIS." THE INVESTIGATOR ASSESSED THE DEATH EVENT AS NOT RELATED TO THE STUDY DEVICE.

Description of Event or Problem · 1

PREVIOUSLY IT WAS REPORTED THAT THE PATIENT DIED IN (B)(6) 2012, NOW IT IS REPORTED THAT THE PATIENT DIED IN (B)(6) 2012. CLINICAL ASSESSMENT INCLUDES MULTIPLE PATHOLOGIES, POSTOPERATIVE FOR BELOW KNEE AMPUTATION OF LEFT LOWER LIMB, ACUTE KIDNEY INJURY, CONTINUOUS RENAL FILTRATION, ACUTE RESPIRATORY FAILURE, NON-INVASIVE VENTILATION, ISCHEMIA OF SMALL INTESTINE AND EXITUS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
25542 TAXUS? ELEMENT? CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - GALWAY H7493902524250

Patients

Seq Age Sex Outcome Treatment
1 42 YR Required Intervention